Location History:
- Ummendorf, DE (2010)
- Warthausen, DE (2013)
- Erbach, DE (2014)
Company Filing History:
Years Active: 2010-2014
Title: Innovations in Biopharmaceutical Production: The Contributions of Thomas Krieg
Introduction
Thomas Krieg, an accomplished inventor based in Erbach, Germany, has made significant contributions to the field of biopharmaceuticals through his innovative methods and technologies. With a total of four patents to his name, his work focuses primarily on improving the efficiency and effectiveness of protein production, particularly utilizing Chinese hamster ovary (CHO) cells.
Latest Patents
Krieg's most recent patents detail groundbreaking methods for producing proteins in CHO cells. One patent introduces a new method for selecting clones and recloning mammalian cells with a high degree of automation and throughput, which is crucial for biopharmaceutical production. This invention encompasses techniques for depositing and replicating single-cell clones, enabling more precise protein preparation using efficiently cultured cells.
In another patent, he explores the use of Human Serum Albumin (HSA)-producing cells, creating a framework for cloning important cell lines for biopharmaceuticals. These methods significantly enhance the recloning efficiency, thus increasing the yield of valuable clones in serum-free and insulin-free conditions. This contribution showcases his focus on optimizing cell culture technology to meet the demands of modern medicine.
Career Highlights
Thomas Krieg is currently employed at Boehringer Ingelheim Pharma GmbH & Co. KG, a renowned company in the pharmaceutical industry. His role has allowed him to leverage his expertise in cellular biology to innovate and enhance biopharmaceutical production processes.
Collaborations
Throughout his career, Thomas has collaborated with talented professionals including Juergen Fieder and Ralf Otto. Their collective efforts have enhanced the scope and impact of their research, contributing to advancements in the field of cell culture technology and protein production.
Conclusion
Thomas Krieg's work embodies the spirit of innovation that drives the biopharmaceutical industry forward. His inventions not only showcase technical proficiency but also reflect a deep understanding of the needs and challenges faced by researchers and companies alike in the production of biopharmaceuticals. Through his continued efforts, he remains a pivotal figure in advancing the capabilities of cell culture technologies in medicine.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.